Pap smear screening in an urban STD clinic. Yield of screening and predictors of abnormalities

Sexually Transmitted Diseases

Volumn 25, Issue 9, 1998, Pages 468-475

  Shlay, Judith C ^a,b   Mcgill, William L ^a   Masloboeva, Heidi A ^a   Douglas Jr , John M ^a,c  

^a Denver Disease Control Service   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACRON;

ADOLESCENT; ADULT; AGE; ARTICLE; CLINICAL PROTOCOL; CONDYLOMA; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; SCREENING; SEXUALLY TRANSMITTED DISEASE; SQUAMOUS EPITHELIUM; URBAN AREA; UTERINE CERVIX DYSPLASIA;

ADOLESCENT; ADULT; AGE FACTORS; CERVIX UTERI; COLORADO; FEMALE; HUMANS; MEDICAL RECORDS; MULTIVARIATE ANALYSIS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SEXUALLY TRANSMITTED DISEASES; URBAN HEALTH; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0031724911     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199810000-00005     Document Type: Article

References (51)

1. CDC. Chronic disease reports: death from cervical cancer - United States, 1984-1986. MMWR 1989; 38:650-659.
2. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin 1994; 44:7-26.
3. Munoz N, Bosch FX, Shah KV, et al., eds. The epidemiology of cervical cancer and human papillomavirus. Lyon, France: International Agency for Research on Cancer, 1992. IARC scientific publication No. 119.
4. Rotkin ID. A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res 1973; 33:1353-1367.
5. Hakama M, Miller AB, Day NE, eds. Screening for cancer of the uterine cervix. Lyon, France: International Agency for Research on Cancer, 1986. IARC scientific publication No. 76.
6. Reeves WC, Rawls WE, Brinton LA. Epidemiology of genital human papillomavirus and cervical cancer. Rev Infect Dis 1989; 11:426-439.
7. Schachter J, Hill EC, King EB, et al. Chlamydia trachomatis and cervical neoplasia. JAMA 1982; 248:2134-2138.
8. Levin ML, Kress LC, Goldstein H. Syphilis and cancer: reported syphilis prevalence among 7,761 cancer patients. NY State J Med 1942; 42:1737-1745.
9. Slattery ML, Overall JC, Abbott TM, French TK, Robinson LM, Gardner J. Sexual activity, contraception, genital infections, and cervical cancer: support for a sexually transmitted disease hypothesis. Am J Epidemiol 1989; 130:248-258.
10. Kamb M. Cervical cancer screening of women attending sexually transmitted disease clinics. Clin Inf Dis 1995; 20:S98-S103.
11. Lucas AJ, Williams DR. Cervical cytology of patients attending a venereal disease clinic. J Obstet Gynaec Brit Cwlth 1967; 74:104-110.
12. Briggs RM, Holmes KK, Kiviat N, Barker E, Eschenbach DA, DeJong R. High prevalence of cervical dysplasia in STD clinic patients warrants routine cytologic screening. Am J Public Health 1980; 70:1212-1214.
13. Tavelli BG, Judson FN, Hetrick AE, Root CJ. Cost-yield of routine Papanicolaou smear screening in a clinic for sexually transmitted diseases. Sex Transm Dis 1985; 12:110-113.
14. Lyttle H, Platts WM, MacLean AB. Pilot study of cervical cytology screening in a sexually transmitted disease clinic. Genitourin Med 1985; 61:330-334.
15. Campbell PJ, Hewitt SH, Kowalchuk PA, Joffres M, Romanowski B. Relationship of cervical cytologies to selected variables among women attending a sexually transmitted disease clinic. Int J STD AIDS 1994; 5:108-112.
16. British Co-operative Clinical Group. Cervical cytology screening in sexually transmitted diseases clinics in the United Kingdom. Genitourin Med 1987; 63:40-43.
17. Eckert LO, Koutsky LA, Kiviat NB, Krone MR, Stevens CE, Eschenbach DA. The inflammatory Papanicolaou smear: what does it mean? Obstet Gynecol 1995; 86.360-366.
18. Amsel R, Totten PA, Spiegel CA, Chen KCS, Eschenbach D, Holmes KK. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiological associations. Am J Med 1983; 74:14-22.
19. National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. JAMA 1989; 262:931-934.
20. Baker NJ, Nelder JA. The Glim System, release 3. Oxford: Numerical Algorithms Group, 1978.
21. Murata PJ, Johnson RA, McNicoll KE. Controlled evaluation of implementing the cytobrush technique to improve Papanicolaou smear quality. Obstet Gynecol 1990; 75:690-695.
22. Tauchi-Nishi PS, Gajda R, Namiki TS. Quality assurance report for improving specimen adequacy in gynecologic cytology. CAP Today 1991; 5:12.
23. Kaufman RH. Atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion: diagnostic criteria and management. Am J Obstet Gynecol 1996; 175:1120-1128.
24. Davey DD, Naryshkin S, Nielsen ML, Kline TS. Atypical squamous cells of undetermined significance: interlaboratory comparison and quality assurance monitors. Diagn Cytopathol 1994; 11:390-396.
25. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH; for the 1992 National Cancer Institute Workshop. Interim guidelines for management of abnormal cervical cytology. JAMA 1994; 271:1866-1869.
26. Paavonen J, Kiviat NB, Wolner-Hanssen P, et al. Significance of mild cervical cytologic atypia in a sexually transmitted disease clinic population. Acta Cytol 1989; 33:831-838.
27. Montz FJ, Monk BJ, Fowler JM, Nguyen L. Natural history of the minimally abnormal Papanicolaou smear. Obstet Gynecol 1992; 80:385-388.
28. Kinlen LJ, Spriggs AI. Women with positive cervical smears but without surgical intervention: a follow-up study. Lancet 1978; 2:463-465.
29. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995; 172:946-954.
30. Wright TC, Sun XW, Koulos J. Comparison of management algorithms for evaluation of women with low-grade cytologic abnormalities. Obstet Gynecol 1995; 85:202-210.
31. Guijon FB, Paraskevas M, Brunham R. The association of sexually transmitted diseases with cervical intraepithelial neoplasia: a case-control study. Am J Obstet Gynecol 1985; 151:185-190.
32. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993; 85:958-964.
33. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423-428.
34. Burk RD, Ho GYF, Beardsley L, Lempa M, Peters M, Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis 1996; 174:679-689.
35. Ley C, Bauer HM, Reingold A, et al. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 1991; 83:997-1003.
36. Burk RD, Kelly P, Feldman J, et al. Declining prevalence of cervicovaginal human papilloma virus infection with age is independent of other risk factors. Sex Transm Dis 1996; 23:333-341.
37. Frangopoulou E, Linos A, Mentzelopoulou P, Papaefthimiou M, Efstratiadou M. Changing cytologic detection rates for cervical intraepithelial neoplasia and invasive cancer in a population lacking a mass screening program. Acta Cytol 1989; 33:839-842.
38. Mitchell H, Medley G. Age and time trends in the prevalence of cervical intraepithelial neoplasia on Papanicolaou smear tests, 1970-1988. Med J Aust 1990; 152:252-255.
39. La Vecchia C, Franceschi S, Decarli A, et al. Sexual factors, venereal diseases, and the risk of intraepithelial and invasive cervical neoplasia. Cancer 1986; 58:935-941.
40. ACOG committee opinion. Recommendations on frequency of Pap test screening. Int J Gynecol Obstet 1995; 49:210-211.
41. CDC. 1998 guidelines for treatment of sexually transmitted diseases. MMWR 1997; 47:95-98.
42. O'Mahoney C. There is no longer a place for underage cytology in genitourinary clinics. Genitourin Med 1996; 72:433-434.
43. Olamijulo J, Duncan ID. Is cervical cytology screening of teenagers worthwhile? Br J Obstet Gyneacol 1995; 102:515-516.
44. Hillard P. Adolescent Pap smear screening: yes or no. J Pediatr Adolesc Gynecol 1996; 9:93-97.
45. Van Oortmarssen GJ, Habbema JD. Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer 1991; 64:559-565.
46. Bell S, Porter M, Kitchener H, Fraser C, Fisher P, Mann E. Psychological response to cervical screening. Prev Med 1995; 24:610-616.
47. Jones MH, Singer A, Jenkins D. The mildly abnormal cervical smear: patient anxiety and choice of management. JR Soc Med 1996; 89:257-260.
48. Hillard PA, Biro FM, Wildey L. Complications of cervical cryotherapy in adolescents. J Reprod Med 1991; 36:711-716.
49. Koutsky LA, Holmes KK, Critchlow CW, et al. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992; 327:1272-1278.
50. Syränen K. Väyrynen M, Castrén O, et al. Sexual behavior of women with human papillomavirus (HPV) lesions of the uterine cervix. Br J Vener Dis 1984; 60:243-248.
51. Celum CL, Bolan G, Krone M, et al. Patients attending STD clinics in an evolving health care environment: demographics, insurance coverage, preferences for STD services, and STD morbidity. Sex Transm Dis 1997; 24:599-605.